Chlorpromazine: from antihistamine to antipsychotic
While chlorpromazine’s use on people with schizophrenia has been overtaken by atypical antipsychotics, it is still used widely.
New labelling will lead to safer antibiotic treatment
A new initiative to transform how pharmacists label antibiotics has been praised by the Federal Department of Health.
Another vaccine-preventable disease makes a resurgence
Once a disease of the past, diphtheria is rapidly re-emerging across Australia. Here’s what pharmacists need to know.
Pharmacists end 2021 on a high note at PSA Pharmacy Awards
Last week, pharmacists in the ACT and Victoria were honoured with PSA Pharmacy Awards for hard work and dedication, through the COVID-19 pandemic and beyond.
The peptide surge has reached compounding
Demand for unapproved peptide products has moved from the black market to compounding pharmacies. Here's what pharmacists need to know.
Dexamethasone and COVID-19
A cheap and widely used corticosteroid may be employed by Australian doctors in the treatment of seriously ill COVID-19 patients.
